The
Government is promoting Indian Systems of Medicines in the Country. Following
activities are being carried out to promote Ayurveda,
Yoga & naturopathy, Unani, Siddha
and Homoeopathy
i. Standardization of drugs.
ii.
Production and Quality control of raw material (Medicinal Plants).
iii.
Production of Quality Assurance of drugs
iv.
Raising the standards of Research and Education
v.
Generation of awareness
The
allocation/outlay for the current financial year in respect of AYUSH vis-à-vis Allopathic discipline
is given as under:-
(Rs. in crores)
|
|
Plan
|
Non Plan
|
Total
|
|
AYUSH
|
734.00
|
188.00
|
922
|
|
Allopathy Systems
|
18380.00
|
2733.33
|
21113.33
|
The
following steps are being taken to increase India’s share in global market of
herbal medicines
i. Reimbursement of 50% of the expenditure limited to Rs. 1.00 lakh to AYUSH entrepreneurs, industry representatives etc. for participating in international
exhibitions, trade fairs, roadshows etc.
ii.
Reimbursement of 50% of the expenditure incurred on preparation of Drug Dossiers and
Registration of ASU&H products by US-FDA/EMEA/UK-MHRA subject to a maximum limit of Rs.5.00 lakhs per product to AYUSH units for encouraging them
to register their products for export.
iii.
Funding of upto Rs. 50 lakhs for market development linked activities and to
organize or support international conferences,
seminars, workshops, conduct of market surveys
& studies, etc.
iv.
A Centre for Research on Indian System of Medicine (CRISM) has been set up in
the National Centre for Natural Products Research (NCNPR), University of Mississippi,
USA. The NCNPR has an institutional interface with US-FDA
which will facilitate Ayurveda, Siddha and Unani drug
manufacturing companies to get their herbal
medicines/food supplements registered on the basis
of Common technical dossiers to be
prepared jointly by CRISM and ASU Industry partners.
v.
Framework of Cooperation has been signed with International
Trade Center,
UNCTAD/WTO, Geneva
for development of International Trade of Indian Traditional Medicinal Products and Services.
vi. Collaborative project on preparation
of drug dossiers for market authorization in the EU to meet the regulatory
requirements under the Traditional Herbal Medicinal Products Directive (THMPD)
is being taken up.
This information was given by Shri Gandhiselvan, Minister of
State for Health & Family Welfare in a written reply to a question in the Lok Sabha today.
DS/GK